Showing results (121-130 of 136) with videos related to
Sort By:
Pageof 14
Animals : an Open Access Journal From MDPI|November 11, 2022
Evaluation of Protective Immune Responses Induced in BALB/c Mice and Goats by the Neospora caninum Surface SRS Proteins and Interleukin-18Pu Wang, Xiaocen Wang, Weirong Wang, et al.Cancer Chemotherapy and Pharmacology|March 17, 2022
Discovery and pharmacological characterization of cetrelimab (JNJ-63723283), an anti-programmed cell death protein-1 (PD-1) antibody, in human cancer modelsNikki DeAngelis, Catherine Ferrante, Gordon Powers, et al.Oxidative Medicine and Cellular Longevity|February 7, 2022
Dapagliflozin Ameliorates the Formation and Progression of Experimental Abdominal Aortic Aneurysms by Reducing Aortic Inflammation in MiceHaole Liu, Panpan Wei, Weilai Fu, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2016
First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28Nicolas Poirier, Gilles Blancho, Maryvonne Hiance, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2012
Lymphatic transport and catabolism of therapeutic proteins after subcutaneous administration to rats and dogsWeirong Wang, Nancy Chen, Xiaolan Shen, et al.Frontiers in Immunology|September 27, 2023
C-reactive protein deficiency ameliorates experimental abdominal aortic aneurysmsYu Fu, Haole Liu, Kexin Li, et al.Journal of Pharmacokinetics and Pharmacodynamics|August 11, 2022
Current practices for QSP model assessment: an IQ consortium surveyJason R Chan, Richard Allen, Britton Boras, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2015
Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White PaperEugenia Kraynov, Amrita V Kamath, Markus Walles, et al.Journal of Pharmaceutical Analysis|April 10, 2026
Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathwayHaole Liu, Kangli Tian, Weilai Fu, et al.Blood Advances|March 10, 2020
A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemiaPriyanka Nair-Gupta, Michael Diem, Dara Reeves, et al.Pageof 14